1. Repositori Institucional (O2)
  2. Recerca
  3. Ciencias de la salud
  4. Articles
Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10609/92814
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorRubio Valera, Maria-
dc.contributor.authorBeneitez, Imma-
dc.contributor.authorPEÑARRUBIA-MARÍA, M TERESA-
dc.contributor.authorLuciano, Juan Vicente-
dc.contributor.authorMendive Arbeloa, Juan Manuel-
dc.contributor.authorMcCrone, Paul-
dc.contributor.authorKnapp, Martin-
dc.contributor.authorSabés Figuera, Ramon-
dc.contributor.authorKocyan, Katarzyna-
dc.contributor.authorGarcia-Campayo, Javier-
dc.contributor.authorSerrano Blanco, Antoni-
dc.contributor.otherUniversitat de Barcelona (UB)-
dc.contributor.otherKing's College London-
dc.contributor.otherLondon School of Economics and Political Science-
dc.contributor.otherUniversidad de Zaragoza-
dc.contributor.otherUniversitat Oberta de Catalunya (UOC)-
dc.date.accessioned2019-04-02T13:44:40Z-
dc.date.available2019-04-02T13:44:40Z-
dc.date.issued2015-03-31-
dc.identifier.citationRubio-Valera, M., Beneitez de Dios, I., Peñarrubia-María, M.T., Luciano Devis, J.V., Mendive, J.M., McCrone, P., Knapp, M., Sabés-Figuera, R., Kocyan, K., García-Campayo, J. & Serrano Blanco, A. (2015). Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). BMC Psychiatry, 15(1). doi: 10.1186/s12888-015-0448-3-
dc.identifier.issn1471-244XMIAR
-
dc.identifier.urihttp://hdl.handle.net/10609/92814-
dc.description.abstractClinical practice guidelines for the treatment of major depressive disorder (MDD) recommend antidepressants for patients with moderate-severe depression and active monitoring for patients with mild-moderate symptoms. The feasibility and efficiency of active monitoring has not been proven conclusively. The aim of this study is to evaluate the cost-effectiveness of active monitoring in comparison to antidepressants for primary care patients with mild-moderate MDD.en
dc.language.isoeng-
dc.publisherBMC Psychiatry-
dc.relation.ispartofBMC Psychiatry, 2015, 15(1)-
dc.relation.urihttps://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-015-0448-3-
dc.rightsCC BY-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/-
dc.subjectdepressive disorderen
dc.subjectantidepressive agentsen
dc.subjectactive monitoringen
dc.subjectwatchful waitingen
dc.subjectcosts and cost analysisen
dc.subjectprimary health careen
dc.subjecttrastorn depressiuca
dc.subjectagents antidepressiusca
dc.subjectmonitorització activaca
dc.subjectesperar vigilantca
dc.subjectcostos i anàlisi de costosca
dc.subjectatenció primària de salutca
dc.subjectdesorden depresivoes
dc.subjectagentes antidepresivoses
dc.subjectmonitoreo activoes
dc.subjectespera vigilantees
dc.subjectcostes y análisis de costeses
dc.subjectatención primaria de saludes
dc.subject.lcshDepression, Mentalen
dc.titleCost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)-
dc.typeinfo:eu-repo/semantics/article-
dc.subject.lemacDepressió psíquicaca
dc.subject.lcshesDepresión psíquicaes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.doi10.1186/s12888-015-0448-3-
dc.gir.idAR/0000003868-
dc.type.versioninfo:eu-repo/semantics/publishedVersion-
Aparece en las colecciones: Articles
Articles cientÍfics

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
costeffectiveness.pdf811,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem
Comparte:
Impacto: Google Scholar Microsoft Academic
Exporta:
Consulta las estadísticas

Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons